NASDAQ:BGNE - BeiGene, Ltd.
$119.91
 $3.38
+2.90%
4:00PM EDT
2019-06-19
BeiGene, Ltd. is a clinical-stage biopharmaceutical company. The Company is focused in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company had used its cancer biology platform to develop four clinical-stage drug candidates, such as BGB-3111, BGB-A317, BGB-290 and BGB-283, as of December 31, 2016. BGB-3111, BGB-290 and BGB-283 are its molecularly targeted agents and is its immuno-oncology agent. BGB-3111 is a potent and highly selective small molecule inhibitor of Bruton's tyrosine kinase (BTK). BGB-283 is a molecule inhibitor of both the monomer and dimer forms of the RAF kinase. BGB-290 is a molecularly targeted, orally available, potent and highly selective inhibitor of the poly ADP ribose polymerase (PARP) family members. BGB-A317 is an investigational humanized monoclonal antibody against the immune checkpoint receptor, PD-1. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  BGNE     avg for
industry  
  avg for
sector  
42 stocks weight:  230. 96   0. 00   0. 00  
42 stocks rank:  599. 00   912. 56   510. 16  
# analyst opinions:  13. 00   14. 57   14. 13  
mean recommendation:  1. 60   2. 13   2. 02  

quick ratio:  7. 04   5. 37   1. 91  
current ratio:  7. 52   5. 75   2. 41  

target price low:  150. 00   83. 40   114. 04  
target price avg:  185. 56   106. 54   136. 01  
target price high:  214. 00   132. 54   156. 72  
1-yr high:  189. 66   111. 02   139. 63  
last close:  116. 53   88. 45   123. 79  
50-day avg:  126. 00   87. 85   119. 44  
200-day avg:  135. 57   90. 65   120. 54  
1-yr low:  107. 01   72. 31   99. 15  
volume:  528. 65 K 1. 87 M 3. 02 M
50-day avg volume:  319. 98 K 2. 60 M 4. 48 M
200-day avg volume:  405. 66 K 2. 91 M 4. 74 M

1-day return:  2. 23 % 1. 12 % 1. 06 %
this week return:  -0. 93 % 3. 47 % 1. 92 %
12-wk return:  -11. 72 % -0. 35 % 1. 47 %
52-wk return:  -30. 96 % -0. 93 % 11. 48 %

enterprise value (EV):  5. 49 B 49. 86 B 123. 38 B
market cap:  6. 97 B 44. 36 B 111. 46 B
EBITDA:  -757. 16 M 4. 52 B 8. 29 B
enterprise multiple (EV/EBITDA):  -7. 25   5. 54   11. 93  
enterprise/revenue (EV/R):  22. 53   46. 49   9. 04  
total revenue:  243. 51 M 10. 64 B 39. 68 B
total debt:  270. 59 M 11. 75 B 17. 53 B
debt/equity:  16. 68   57. 16   119. 72  
net income (common):  -736. 81 M 2. 20 B 4. 36 B

shares outstanding:  59. 79 M 573. 99 M 1. 25 B
shares:  30. 87 M 574. 72 M 1. 24 B
shares short:  3. 63 M 9. 66 M 12. 27 M
shares short prior month:  3. 68 M 9. 99 M 11. 00 M
short ratio:  11. 42   6. 01   3. 31  
total cash/share:  26. 98   11. 03   9. 06  
total cash:  1. 61 B 6. 13 B 6. 05 B
free cash flow:  -523. 54 M 3. 17 B 5. 16 B
operating cash flow:  -615. 19 M 4. 10 B 6. 09 B

book value:  26. 91   12. 98   26. 51  
price/book:  4. 33   3. 73   8. 63  
gross profits:  -509. 49 M 7. 99 B 35. 79 B
operating margins:  -315. 68 % -344. 86 % -34. 50 %
EBITDA margins:  0. 00 % 13. 91 % 23. 37 %
profit margins:  0. 00 % 10. 93 % 13. 94 %
gross margins:  -223. 22 % 37. 00 % 55. 71 %

1-yr max volatility:  13. 78 % --- ---
1-yr mean volatility:  -0. 09 % 0. 03 % 0. 06 %

1-yr EPS:  -12. 83   2. 25   4. 29  
forward EPS:  -12. 07   3. 67   7. 05  
P/E:  -9. 09   2. 70   31. 26  
forward P/E:  -9. 65   -5. 28   15. 02  
PE/G:  -0. 07   0. 12   -0. 75  
growth:  139. 20 % 262. 99 % 80. 79 %
earnings high:  -2. 11   0. 96   1. 69  
earnings avg:  -2. 99   0. 76   1. 56  
earnings low:  -3. 69   0. 53   1. 44  
revenue high:  80. 58 M 2. 74 B 11. 00 B
revenue avg:  65. 55 M 2. 68 B 10. 83 B
revenue low:  60. 00 M 2. 64 B 10. 64 B
return on assets:  -24. 76 % -2. 04 % 5. 42 %
return on equity:  -49. 44 % -82. 23 % 128. 48 %
revenue growth:  139. 20 % 262. 56 % 72. 43 %
revenue/share:  4. 24   13. 19   58. 52  

beta (1yr vs S&P500):  1. 75   1. 26   0. 92  
sharpe (1yr):  -0. 41   0. 32   0. 89  

held % insiders:  0. 03 % 6. 02 % 3. 25 %
held % institutions:  88. 60 % 78. 70 % 69. 25 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-06-18 : BGNE
.    156.269 =       156.269 :: INITIAL WEIGHT
.   + 66.862 =       223.131 :: inverse volume-to-price addition
.   - 213.76 =         9.372 :: spline projection addition
.    x 1.824 =        17.089 :: 13 weeks' performance factor
.    x 0.809 =        13.832 :: one-year gains+dividend factor
.    x 1.418 =        19.614 :: industry recommendation factor
.    x 3.214 =         63.03 :: company recommendation factor
.    x 1.485 =        93.584 :: EV/R factor
.    x 0.752 =        70.415 :: return on assets factor
.    x 0.506 =        35.602 :: return on equity factor
.    x 2.273 =        80.932 :: revenue growth factor
.    x 2.691 =       217.812 :: current ratio factor
.     x 1.08 =       235.153 :: quick ratio factor
.    x 1.043 =       245.232 :: short ratio factor
.    x 1.053 =       258.294 :: price-to-book factor
.      x 0.9 =       232.443 :: debt-to-revenue factor
.    x 1.137 =       264.182 :: debt-to-equity factor
.    x 2.325 =       614.111 :: P/E factor
.    x 1.978 =      1214.982 :: PE/G factor
.     x 1.41 =      1713.135 :: beta factor
.    x 0.785 =      1344.189 :: sharpe factor
.    x 1.665 =      2237.993 :: target low factor
.    x 1.257 =      2812.158 :: target mean factor
.    x 1.038 =      2920.179 :: target high factor
.    x 1.314 =      3837.857 :: industry 2-weeks return factor
.    x 0.909 =      3488.105 :: "drift" penalty 3 days ago
.    / 4.239 =       822.924 :: overall "drift" factor
.    x 0.862 =       709.548 :: largest single-day jump factor
.     x 1.01 =       716.637 :: mean volatility factor
.    x 1.097 =       786.384 :: 42-day mean volatility factor
.    x 1.002 =       787.977 :: factor hist industry gain for week 24
.   cubeRoot =         9.236 :: reduced to standardize
.  + 221.726 =       230.963 :: add/subtract for investor sentiment
.                    230.963 :: FINAL WEIGHT for NASDAQ:BGNE


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org